Children of addicted women

Journal of Addictive Diseases

Volumn 29, Issue 2, 2010, Pages 259-276

  Lester, Barry M ^a,b   Lagasse, Linda L ^a  

^a BROWN UNIVERSITY   (United States)

^b WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

Fetal origins; Follow up; Prenatal drug exposure

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 2; COCAINE; CORTICOSTERONE; CORTICOTROPIN; DIAMORPHINE; HYDROCODONE BITARTRATE PLUS PARACETAMOL; METHADONE; METHAMPHETAMINE; NEUROTRANSMITTER; NORADRENALIN TRANSPORTER; OPIATE; OXYCODONE;

ACADEMIC ACHIEVEMENT; ADOLESCENCE; ADOLESCENT DEVELOPMENT; ATTENTION; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; BIRTH DEFECT; BRAIN; BRAIN DEVELOPMENT; BRAIN METABOLISM; CHILD BEHAVIOR; CHILD DEVELOPMENT; COGNITION; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DIFFUSION TENSOR IMAGING; DNA METHYLATION; DRUG DEPENDENCE; EMOTIONALITY; EPIGENETICS; FOLLOW UP; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE EXPRESSION; HUMAN; HUMAN RELATION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTELLIGENCE QUOTIENT; LANGUAGE; MENTAL DISEASE; MOTOR PERFORMANCE; NEUROENDOCRINE SYSTEM; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OPPOSITIONAL DEFIANT DISORDER; PATHOPHYSIOLOGY; PATIENT REFERRAL; PRENATAL DRUG EXPOSURE; PRENATAL GROWTH; PRENATAL STRESS; PRESCRIPTION; PSYCHOLOGIC TEST; REVIEW; SMOKING; SUBSTANCE ABUSE; TERATOGENESIS;

ADOLESCENT; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; COCAINE; COCAINE-RELATED DISORDERS; DEVELOPMENTAL DISABILITIES; DOPAMINE UPTAKE INHIBITORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; MALE; OPIOID-RELATED DISORDERS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; TIME;

EID: 77951428289     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550881003684921     Document Type: Review

References (191)

1. Accornero VH, Morrow CE, Banstra ES, Johnson AL, Anthony JC. Behavioral outcome of preschoolers exposed to cocaine: role of maternal behavioral health. J Ped Psych 2002; 27:259-269
2. Bada HS, Das A, Bauer CR, Shankaran S, Lester B, LaGasse L, Hammond J, Wright LL, Higgins R. Impact of prenatal cocaine exposure on child behavior problems through school age. Pediatrics 2007; 119:e348-59.
3. Bendersky M, Bennett D, Lewis M. Aggression at age 5 as a function of prenatal exposure to cocaine, gender, and environmental risk. J Pediatr Psychol 2006; 31: 71-84.
4. Bennett D, Bendersky M, Lewis M. Preadolescent health risk behavior as a function of prenatal cocaine exposure and gender. J Dev Behav Pediatr 2007; 28: 467-472
5. Bennett DS, Bendersky M, Lewis M. Children's intellectual and emotional-behavioral adjustment at 4 years as a function of cocaine exposure, maternal characteristics, and environmental risk. Dev Psych 2002; 38:648-658
6. Covington C, Nordstrom-Klee B, Delaney-Black V, Templin T, Ager J, Sokol RJ. Development of an instrument to assess problem behavior in first grade students prenatally exposed to cocaine. Part II: validation. Subst Abus 2001; 22:217-233
7. Delaney-Black V, Covington C, Nordstrom B, Ager J, Janisse J, Hannigan JH, Chiodo L, Sokol RJ. Prenatal cocaine: quantity of exposure and gender moderation. J Dev Behav Pediatr 2004; 25:254-263
8. Delaney-Black V, Covington C, Templin T, Ager J, Martier S, Sokol R. Prenatal cocaine exposure and child behavior. Pediatrics 1998; 102:945-950
9. Delaney-Black V, Covington C, Templin T, Ager J, Nordstrom-Klee B, Martier S, Leddick L, Czerwinski RH, Sokol RJ. Teacher-assessed behavior of children prenatally exposed to cocaine. Pediatrics 2000; 106:783-791
10. Dennis T, Bendersky M, Ramsay D, Lewis M. Reactivity and regulation in children prenatally exposed to cocaine. Dev Psychol 2006; 42:688-697
11. Kilbride HW, Castor CA, Fuger KL. School-age outcome of children with prenatal cocaine exposure following early case management. J Dev Behav Pediatr 2006; 27:181-187
12. Linares TJ, Singer LT, Kirchner HL, Short EJ, Min MO, Hussey P, Minnes S. Mental health outcomes of cocaine-exposed children at 6 years of age. J Pediatr Psychol 2006; 31:85-97.
13. Nordstrom Bailey B, Sood BG, Sokol RJ, Ager J, Janisse J, Hannigan JH, et al. Gender and alcohol moderate prenatal cocaine effects on teacher-report of child behavior. Neurotoxicol Teratol 2005; 27:181-189 (Pubitemid 40279128)
14. Richardson GA, Conroy ML, Day NL. Prenatal cocaine exposure: effects on the development of school-age children. Neurotoxicol Teratol 1996; 18:627-634
15. Savage J, Brodsky NL, Malmud E, Giannetta JM, Hurt H. Attentional functioning and impulse control in cocaine-exposed and control children at age ten years. J Dev Behav Pediatr 2005; 26:42-47
16. Sood BG, Nordstrom Bailey B, Covington C, Sokol RJ, Ager J, Janisse J, Hannigan JH, Delaney-Black V. Gender and alcohol moderate caregiver reported child behavior after prenatal cocaine. Neurotoxicol Teratol 2005; 27:191-201. (Pubitemid 40279129)
17. Hurt H, Brodsky NL, Roth H, Malmud E, Giannetta JM. School performance of children with gestational cocaine exposure. Neurotoxicol Teratol 2005; 27:203-211
18. Kable JA, Coles CD, Lynch ME, Platzman K. Physiological responses to social and cognitive challenges in 8-year olds with a history of prenatal cocaine exposure. Dev Psychobiol 2008; 50:251-265
19. O'Leary CC, Frank DA, Grant-Knight W, Beeghly M, Augustyn M, Rose-Jacobs R, Cabral HJ, Gannon K. Suicidal ideation among urban nine and ten year olds. J Dev Behav Pediatr 2006; 27:33-39
20. Arendt RE, Short EJ, Singer LT, Minnes S, Hewitt J, Flynn S, et al. Children prenatally exposed to cocaine: developmental outcomes and environmental risks at seven years of age. J Dev Behav Ped 2004; 25:83-90.
21. Asanbe CB, Lockert E. Cognitive abilities of African American children with prenatal cocaine/polydrug exposure. J Health Care Poor Underserved 2006; 17: 400-412
22. Bennett DS,Bendersky M, LewisM.Children's cognitive ability from 4 to 9 years old as a function of prenatal cocaine exposure, environmental risk, and maternal verbal intelligence. Dev Psychol 2008; 44:919-928
23. Frank DA, Rose-Jacobs R, Beeghly M, Wilbur M, Bellinger D, Cabral H. Level of prenatal cocaine exposure and 48-month IQ: importance of preschool enrichment. Neurotoxicol Teratol 2005; 27:15-28.
24. Marques PR, Pokorni JL, Long T, Teti LO.Maternal depression and cognitive features of 9-year-old children prenatally-exposed to cocaine. Am J Drug Alcohol Abuse 2007; 33:45-61.
25. Morrow CE, Culbertson JL, Accornero VH, Xue L, Anthony JC, Bandstra ES. Learning disabilities and intellectual functioning in school-aged children with prenatal cocaine exposure. Dev Neuropsychol 2006; 30:905-931
26. Pulsifer MB, Radonovich K, Belcher HME, Butz AM. Intelligence and school readiness in preschool children with prenatal drug exposure. Child Neuropsychology 2004; 10:89-101.
27. Singer LT, Minnes S, Short E, Arendt R, Farkas K, Lewis B, Klein N, Russ S, Min MO, Kirchner HL. Cognitive outcomes of preschool children with prenatal cocaine exposure. JAMA 2004; 291:2448-2456
28. Singer LT, Nelson S, Short E, Min MO, Lewis B, Russ S, Minnes S. Prenatal cocaine exposure: drug and environmental effects at 9 years. J Pediatr 2008; 153: 105-111
29. Wasserman GA, Kline JK, Bateman DA, Chiriboga C, Lumey LH, FriedlanderH,Melton L, Heagarty MC. Prenatal cocaine exposure and school-age intelligence. Drug Alcohol Depend 1998; 50:203-210
30. Bandstra ES, Morrow CE, Vogel AL, Fifer RC, Ofir AY, Dausa AT, Xue L, Anthony JC. Longitudinal influence of prenatal cocaine exposure on child language functioning. Neurotox Teratol 2002; 24:297-308.
31. Bandstra ES, Vogel AL, Morrow CE, Xue L, Anthony JC. Severity of prenatal cocaine exposure and child language functioning through age seven years: a longitudinal latent growth curve analysis. Substance Use andMisuse 2004; 39:25-59.
32. BeeghlyM,Martin B, Rose-Jacobs R, Cabral H, Augustyn M, Bellinger D, Frank DA. Prenatal cocaine exposure and children's language functioning at 6 and 9.5 years: moderating effects of child age, birthweight, and gender. J Pediatr Psychol 2006; 31:98-115.
33. Lewis BA, Kirchner HL, Short EJ, Minnes S, Weishampel P, Satayathum S, Singer LT. Prenatal cocaine and tobacco effects on children's language trajectories. Pediatrics 2007; 120:e78-85.
34. Lewis BA, Singer Lt SEJ, Minnes S, Arendt R, Weshampel P, Klein N, Min MO. Four year language outcomes of children exposed to cocaine in utero. Neurotoxicol. Teratol. 2004; 26:617-627
35. Accornero VH, Amado AJ, Morrow CE, Xue L, Anthony JC, Bandstra ES. Impact of prenatal cocaine exposure on attention and response inhibition as assessed by continuous performance tests. J Dev Behav Pediatr 2007; 28:195-205.
36. Bandstra ES, Morrow CE, Anthony JC, Accornero VH, Fried PA. Longitudinal investigation of task persistence and sustained attention in children with prenatal cocaine exposure. Neurotoxicol Teratol. 2001; 23: 545-559
37. Bendersky M, Gambini LS, Lastella A, Bennett DS, Lewis M. Inhibitory motor control at five years as a function of prenatal cocaine exposure. J Dev Behav Ped 2003; 24:345-351
38. Noland JS, Singer LT, Short EJ, Minnes S, Arendt RE, Kirchner HL, Bearer C. Prenatal drug exposure and selective attention in preschoolers. Neurotoxicol Teratol 2005; 27:429-438
39. Mayes L, Snyder PJ, Langlois E, Hunter N. Visuospatial working memory in school-aged children exposed in utero to cocaine. Child Neuropsychol 2007; 13:205-218
40. Schroder MD, Snyder PJ, Sielski I, Mayes L. Impaired performance of children exposed in utero to cocaine on a novel test of visuospatial working memory. Brain Cog 2004; 55:409-412
41. Mayes LC, MolfeseDL,KeyAP, Hunter NC. Event- related potentials in cocaine-exposed children during a Stroop task. Neurotoxicol Teratol 2005; 27:797-813.
42. Levine TP, Liu J, Das A, Lester B, Lagasse L, Shankaran S, Bada HS, Bauer CR, Higgins R. Effects of prenatal cocaine exposure on special education in school- aged children. Pediatrics 2008; 122:e83-91.
43. Caldwell B, Bradley R. HOME inventory and administration manual. Littlerock: University of Arkansas for Medical Sciences and University of Arkansas at Littlerock, 2001.
44. Dow-Edwards DL, Benveniste H, BehnkeM, Bandstra ES, Singer LT, Hurd YL, et al. Neuroimaging of prenatal drug exposure. Neurotoxicol Teratol 2006; 28:386-402.
45. Avants BB, Hurt H, Giannetta JM, Epstein CL, Shera DM,Rao H, et al. Effects of heavy in utero cocaine exposure on adolescent caudate morphology. Pediatr Neurol 2007; 37:275-279
46. Neyzi N, Quinn B, Kekatpure D, Kennedy S, Sheinkopf B, Lester B, et al. Automated segmentation of brain structures in a pediatric population with prenatal cocaine exposure. In: 2007 meeting of the Society for Neuroscience. San Diego, CA; 2007.
47. Rivkin MJ, Davis PE, Lemaster JL, Cabral HJ, Warfield SK, Mulkern RV, Robson CD, Rose-Jacobs R, Frank DA. Volumetric MRI study of brain in children with intrauterine exposure to cocaine, alcohol, tobacco, and marijuana. Pediatrics 2008; 121:741-750
48. Warner TD, Behnke M, Eyler FD, Padgett K, Leonard C, Hou W, Garvan CW, Schmalfuss IM, Blackband SJ. Diffusion tensor imaging of frontal white matter and executive functioning in cocaine-exposed children. Pediatrics 2006; 118:2014-2024
49. Smith LM, Chang L, YonekuraML, Grob C, Osborn D, Ernst T. Brain proton magnetic resonance spectroscopy and imaging in children exposed to cocaine in utero. Pediatrics 2001; 107:227-231 (Pubitemid 32121234)
50. RaoH,Wang J,Giannetta J,Korczykowski M, Shera D, Avants BB, Gee J, Detre JA, Hurt H. Altered resting cerebral blood flow in adolescents with in utero cocaine exposure revealed by perfusion functional MRI. Pediatrics 2007; 120:e1245-54.
51. Hurt H, Giannetta JM, Korczykowski M, Hoang A, Tang KZ, Betancourt L, Brodsky NL, Shera DM, Farah MJ, Detre JA. Functional magnetic resonance imaging and working memory in adolescents with gestational cocaine exposure. J Pediatr 2008; 152:371-377
52. Sheinkopf SJ, Lester BM, Sanes JN, Eliassen JC, Hutchison ER, Seifer R, Lagasse LL, Durston S, Casey BJ. Functional MRI and response inhibition in children exposed to cocaine in utero. Dev Neurosci 2009; 31(1- 2):159-166
53. Smith LM, Chang L, YonekuraML, Grob C, Osborn D, Ernst T. Brain proton magnetic resonance spectroscopy in children exposed to methamphetamine in utero. Neurology 2001; 57:255-260 (Pubitemid 32667358)
54. Wouldes T, LaGasse L, Sheridan J, Lester B. Maternal methamphetamine use during pregnancy and child outcome: what do we know? NZ Med J 2004; 117(1206):1-10.
55. Lester B, Das A, LaGasse L, Seifer R, Bauer C, Shankaran S, Bada H, Messinger D, Wright L, Smeriglio V, PooleK. Prenatal cocaine exposure and 7-year outcome: IQ and special education. Ped Res 2004; 53:534A.
56. Cernerud L, Eriksson M, Jonsson B, Steneroth G, Zetterstrom R. Amphetamine addiction during pregnancy: 14-year follow-up of growth and school performance. Acta Paediatr 1996; 85:204-208
57. Billing L, Eriksson M, Steneroth G, Zetterstrom R. Pre-school children of amphetamine-addicted mothers. I. Somatic and psychomotor development. Acta Paediatr Scand 1985; 74:179-184 (Pubitemid 15137069)
58. Billing L, Eriksson M, Steneroth G, Zetterstrom R. Predictive indicators for adjustment in 4-year-old children whose mothers used amphetamine during pregnancy. Child Abuse Negl 1988; 12:503-507
59. Billing L, Eriksson M, Jonsson B, Steneroth G, Zetterstrom R. The influence of environmental factors on behavioral problems in 8-year-old children exposed to amphetamine during fetal life. Child Abuse Negl 1994; 18: 3-9.
60. Chang L, Smith LM, LoPresti C, Yonekura ML, Kuo J, Walot I, Ertist T. Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Res 2004; 132:95-106.
61. Kaltenbach KA. Exposure to opiates: behavioral outcomes in preschool and school- age children. NIDA.Res.Monogr. 1996; 164:230-241
62. Hans SL. Prenatal drug exposure: behavioral functioning in late childhood and adolescence. NIDA Res Monogr 1996; 164:261-276
63. Wilson GS,McCreary R, Kean J, Baxter JC. The development of preschool children of heroin-addicted mothers: a controlled study. Pediatrics 1979; 63:135-141
64. Sowder B, Burt M. Children of Heroin addicts: an assessment of health, learning, behavioral, and adjustment problems. New York, NY: Praeger, 1980.
65. de Cubas MM, Field T. Children of methadone- dependent women: developmental outcomes. Am J Orthopsychiatry 1993; 63:266-276
66. Lifschitz MH, Wilson GS, Smith EO, Desmond MM. Factors affecting head growth and intellectual function in children of drug addicts. Pediatrics 1985; 75: 269-274
67. Kaltenbach K, Finnegan L. Children exposed to methadone in-utero: Assessment of developmental and cognitive ability. Ann N Y Acad Sci 1989; 562:360-362.
68. Strauss ME, Lessen-Firestone JK, Chavez CJ, Stryker JC. Children of methadone-treated women at five years of age. Pharmacol Biochem Behav 1979; 11(Suppl): 3-6.
69. Wilson GS. Clinical studies of infants and children exposed prenatally to heroin. Ann N Y Acad Sci 1989; 562:183-194
70. Olofsson M, Buckley W, Andersen GE, Friis- Hansen B. Investigation of 89 children born by \drug-dependent mothers. II. Follow-up 1-10 years after birth. Acta Paediatr Scand 1983; 72:407-410 (Pubitemid 13088020)
71. Hejanic B, Barredo V, Hejanic M, Tomelleri C. Children of heroin addicts. Inter J Addict 1979; 14:919-931
72. Nichtem S. The children of drug users. J Amer Acad Child Adolesc Psych 1973; 12:24-31.
73. Davis DD, Templer DI. Neurobehavioral functioning in children exposed to narcotics in utero. Addict Behav 1988; 13:275-283
74. Moe V. Foster-placed and adopted children exposed in utero to opiates and other substances: prediction and outcome at four and a half years. J Dev Behav Pediatr 2002; 23:330-339
75. Gogtay N, Giedd JN, Lusk L, Hayashi KM, Greenstein D, Vaituzis AC, Nugent TF, 3rd, Herman DH, Clasen LS, Toga AW, Rapoport JL, Thompson PM. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci USA 2004; 101:8174-8179
76. Ornoy A, Segal J, Bar-Hamburger R, Greenbaum C. Developmental outcome of school-age children born to mothers with heroin dependency: importance of environmental factors. Dev Med Child Neurol 2001; 43:668-675
77. Hickey JE, Suess PE, Newlin DB, Spurgeon L, Porges SW. Vagal tone regulation during sustained attention in boys exposed to opiates in utero. Addict Behav 1995; 20:43-59.
78. Walhovd KB, Moe V, Slinning K, Due-Tonnessen P, Bjornerud A, Dale AM, van der Kouwe A, Quinn BT, Kosofsky B, GreveD, FischlB.Volumetric cerebral characteristics of children exposed to opiates and other substances in utero. Neuroimage 2007; 36:1331-1344
79. Lester B, Padbury J. The Third Pathophysiology of Prenatal Cocaine Exposure. Dev Neurosci 2009; 31(1- 2):23-35.
80. Barker DJ, Osmond C, Rodin I, Fall CH,Winter PD. Low weight gain in infancy and suicide in adult life. BMJ 1995; 311:1203.
81. Gluckman PD, Hanson MA. Living with the past: evolution, development, and patterns of disease. Science 2004; 305:1733-1736
82. Welberg LA, Seckl JR. Prenatal stress, glucocorticoids and the programming of the brain. J Neuroendocrinol 2001; 13:113-128
83. Barker D. Fetal programming of coronary heart disease. Trends Endocrinol Metab 2002; 13:364-368
84. Barker DJ. The fetal origins of adult hypertension. J Hypertens Suppl 1992; 10:S39-44.
85. Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 1989; 298:564-567
86. Falkner B. Birth weight as a predictor of future hypertension. Am J Hypertens 2002; 15(2 Pt 2):43S-5S.
87. Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, Osmond C, Winter PD. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 1991; 303(6809):1019-1022
88. McMillen IC, Robinson JS. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 2005; 85:571-633.
89. Ong KK, Dunger DB. Birth weight, infant growth and insulin resistance. Eur J Endocrinol 2004; 151(Suppl 3):U131-9.
90. Phillips D, Barker D, Hales C, Hirst S, Osmond C. Thinness at birth and insulin resistance in adult life. Diabetologia 1994; 37:150-154 (Pubitemid 24042883)
91. Rich-Edwards JW, Colditz GA, Stampfer MJ, WillettWC, GillmanMW, Hennekens CH, Speizer FE,Manson JE. Birthweight and the risk for type 2 diabetes mellitus in adult women. Ann Intern Med 1999; 130(4 Pt 1):278-284
92. Sallout B, Walker M. The fetal origin of adult diseases. J Obstet Gynaecol 2003; 23:555-560
93. Stein CE, Fall CH, Kumaran K, Osmond C, Cox V, Barker DJ. Fetal growth and coronary heart disease in south India. Lancet 1996; 348:1269-1273
94. Allin M, Rooney M, Cuddy M, Wyatt J, Walshe M, Rifkin L, Murray R. Personality in young adults who are born preterm. Pediatrics 2006; 117:309-316
95. Gale CR, Martyn CN. Birth weight and later risk of depression in a national birth cohort. Br J Psychiatry 2004; 184:28-33.
96. Thompson C, Syddall H, Rodin I,Osmond C, Barker DJ. Birth weight and the risk of depressive disorder in late life. Br J Psychiatry 2001; 179:450-455
97. Wals M, Reichart CG, Hillegers MH, Van Os J, Verhulst FC, Nolen WA, Ormel J. Impact of birth weight and genetic liability on psychopathology in children of bipolar parents. J Am Acad Child Adolesc Psychiatry 2003; 42:1116-1121
98. Matthews SG. Antenatal glucocorticoids and the developing brain: mechanisms of action. Semin Neonatol 2001; 6:309-317
99. Slotkin TA, Orband-Miller L, Queen KL,Whitmore WL, Seidler FJ. Effects of prenatal nicotine exposure on biochemical development of rat brain regions: maternal drug infusions via osmotic minipumps. J Pharmacol Exp Ther 1987; 240:602-611
100. Williams MT, Hennessy MB, Davis HN. Stress during pregnancy alters rat offspring morphology and ultrasonic vocalizations. Physiol Behav 1998; 63:337-343
101. Barbazanges A, Piazza PV, Le Moal M, Maccari S. Maternal glucocorticoid secretion mediates long-term effects of prenatal stress. J Neurosci 1996; 16:3943-3949
102. Henry C, Kabbaj M, Simon H, Le Moal M, Maccari S. Prenatal stress increases the hypothalamo-pituitary- adrenal axis response in young and adult rats. J Neuroendocrinol 1994; 6:341-345
103. Maccari S, Piazza PV, Kabbaj M, Barbazanges A, Simon H, Le Moal M. Adoption reverses the long-term impairment in glucocorticoid feedback induced by prenatal stress. J Neurosci 1995; 15(1 Pt 1):110-116
104. Vallee M, Mayo W, Dellu F, Le Moal M, Simon H, Maccari S. Prenatal stress induces high anxiety and postnatal handling induces low anxiety in adult offspring: correlation with stress-induced corticosterone secretion. J Neurosci 1997; 17:2626-2636
105. Fride E, Dan Y, Feldon J, Halevy G, Weinstock M. Effects of prenatal stress on vulnerability to stress in prepubertal and adult rats. Physiol Behav 1986; 37:681-687
106. Pfister HP, Muir JL. Prenatal exposure to predictable and unpredictable novelty stress and oxytocin treatment affects offspring development and behavior in rats. Int J Neurosci 1992; 62(3-4):227-241
107. Poltyrev T, Keshet GI, Kay G, Weinstock M. Role of experimental conditions in determining differences in exploratory behavior of prenatally stressed rats. Dev Psychobiol 1996; 29:453-462
108. Wakshlak A, Weinstock M. Neonatal handling reverses behavioral abnormalities induced in rats by prenatal stress. Physiol Behav 1990; 48:289-292
109. Takahashi LK, Haglin C, Kalin NH. Prenatal stress potentiates stress-induced behavior and reduces the propensity to play in juvenile rats. Physiol Behav 1992; 51:319-323
110. Takahashi LK, Turner JG, Kalin NH. Prenatal stress alters brain catecholaminergic activity and potentiates stress-induced behavior in adult rats. Brain Res 1992; 574:131-137
111. Lambert KG, Kinsley CH, Jones HE, Klein SL, Peretti SN, Stewart KM. Prenatal stress attenuates ulceration in the activity stress paradigm. Physiol Behav 1995; 57:989-994
112. Weller A, Glaubman H, Yehuda S, Caspy T, Ben- Uria Y. Acute and repeated gestational stress affect offspring learning and activity in rats. Physiol Behav 1988; 43:139-143
113. Hayashi A, Nagaoka M, Yamada K, Ichitani Y, Miake Y, Okado N. Maternal stress induces synaptic loss and developmental disabilities of offspring. Int J Dev Neurosci 1998; 16:209-216
114. Szuran T, Zimmermann E, Welzl H. Water maze performance and hippocampal weight of prenatally stressed rats. Behav Brain Res 1994; 65:153-155
115. Vallee M, MacCari S, Dellu F, Simon H, Le Moal M, MayoW. Long-term effects of prenatal stress and postnatal handling on age-related glucocorticoid secretion and cognitive performance: a longitudinal study in the rat. Eur J Neurosci 1999; 11:2906-2916
116. Meaney M, Seckl J. Glucocorticoid programming. Ann N Y Acad Sci 2004; 1032:63-84.
117. Roughton EC, Schneider ML, Bromley LJ, Coe CL. Maternal endocrine activation during pregnancy alters neurobehavioral state in primate infants. Am J Occup Ther 1998; 52:90-98
118. Schneider M, Moore C, Kraemer G. Moderate level alcohol during pregnancy, prenatal stress, or both and limbic-hypothalamic-pituitary-adrenocortical axis response to stress in rhesus monkeys. Child Dev 2004; 75:96-109.
119. Schneider ML. Prenatal stress exposure alters postnatal behavioral expression under conditions of novelty challenge in rhesus monkey infants. Dev Psychobiol 1992; 25:529-540
120. McEwen BS. Glucocorticoid-biogenic amine interactions in relation to mood and behavior. Biochem Pharmacol 1987; 36:1755-1763
121. Maes M, Meltzer HY, D'Hondt P, Cosyns P, Blockx P. Effects of serotonin precursors on the negative feedback effects of glucocorticoids on hypothalamic- pituitary-adrenal axis function in depression. Psychoneuroendocrinology 1995; 20:149-167
122. Meador-Woodruff JH, Greden JF, Grunhaus L, Haskett RF. Severity of depression and hypothalamic- pituitary-adrenal axis dysregulation: identification of contributing factors. Acta Psychiatr Scand 1990; 81:364-371
123. Nemeroff CB, Widerlov E, Bissette G, Walleus H, Karlsson I, Eklund K, Kilts CD, Loosen PT, Vale W. Elevated concentrations of CSF corticotropin- releasing factor-like immunoreactivity in depressed patients. Science 1984; 226(4680):1342-1344
124. van Praag HM. Depression. Lancet 1982; 2:1259-1264
125. Wadhwa PD, Garite TJ, Porto M, Glynn L, Chicz- DeMet A, Dunkel-Schetter C, Sandman CA. Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fetal growth restriction: a prospective investigation. Am J Obstet Gynecol 2004; 191:1063-1069
126. Wadhwa PD, Sandman CA, Garite TJ. The neurobiology of stress in human pregnancy: implications for prematurity and development of the fetal central nervous system. Prog Brain Res 2001; 133:131-142
127. Lou HC, Hansen D, Nordentoft M, Pryds O, Jensen F, Nim J, Hemmingsen R. Prenatal stressors of human life affect fetal brain development. Dev Med Child Neurol 1994; 36:826-832
128. van Os J, Selten J. Prenatal exposure to maternal stress and subsequent schizophrenia. Br J Psychiatry 1998; 172:324-326
129. Field T. Stress and coping from pregnancy through the postnatal period. In: Cummings EG, Greene AL, eds. Life-Span developmental psychology: perspectives on stress and coping. Hillsdale, NJ: Lawrence Erlbaum Associates; 199:45-59.
130. Huizink AC, Robles de Medina PG, Mulder EJ, Visser GH, Buitelaar JK. Stress during pregnancy is associated with developmental outcome in infancy. J Child Psychol Psychiatry 2003; 44:810-818
131. Levy-Shiff R, Dimitrovsky L, Shulman S, et al. Cognitive appraisals, coping strategies, and support resources as correlates of parenting and infant development. Dev Psychobiol 1998; 34:1417-1427
132. MeijerA.Child psychiatric sequelae ofmaternalwar stress. Acta Psychiatr Scand 1985; 72:505-511
133. Stott DH. Follow-up study from birth of the effects of prenatal stresses. Dev Med Child Neurol 1973; 15:770-787
134. Ward AJ. Prenatal stress and childhood psychopathology. Child Psychiatry Hum Dev 1991; 22:97-110.
135. DePietro J. The role of prenatal maternal stress in child development. Current Directions in Psychological Science 2004; 13:71-74
136. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med 1998; 338:171-179
137. McEwen BS. Early life influences on life-long patterns of behavior and health. Ment Retard Dev Disabil Res Rev 2003; 9:149-154
138. Meyer JS. Biochemical effects of corticosteroids on neural tissues. Physiol Rev 1985; 65:946-1020.
139. Benediktsson R, Lindsay RS, Noble J, Seckl JR, Edwards CR. Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 1993; 341:339-341
140. McTernan CL, Draper N, Nicholson H, Chalder SM, Driver P, Hewison M, Kilby MD, Stewart PM. Reduced placental 11beta-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms. J Clin Endocrinol Metab 2001; 86:4979-4983
141. Murphy VE, Zakar T, Smith R, Giles WB, Gibson PG, Clifton VL. Reduced 11beta-hydroxysteroid dehydrogenase type 2 activity is associated with decreased birth weight centile in pregnancies complicated by asthma. J Clin Endocrinol Metab 2002; 87:1660-1668
142. Shams M, Kilby MD, Somerset DA, Howie AJ, Gupta A, Wood PJ, et al. 11Beta-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction. Hum Reprod 1998; 13:799-804.
143. Stewart P, Roberson F, Mason J. Type 2 11- hydroxysteroid dehydrogenase messenger RNA and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal steroidogenesis. J Clin Endocrinol Metab 1995; 80:885-890
144. Dave-Sharma S, Wilson R, Harbison M. Extensive personal experience: examination of genotype and phenotype relationships in 14 patientswith apparent mineralocorticoid excess. J Clin Endocrinol Metab 1998; 83:2244-2254
145. Seckl JR, Cleasby M, Nyirenda MJ. Glucocorticoids, 11beta-hydroxysteroid dehydrogenase, and fetal programming. Kidney Int. 2000; 57:1412-1417
146. Edwards CR, Benediktsson R, Lindsay RS, Seckl JR. Dysfunction of placental glucocorticoid barrier: link between fetal environment and adult hypertension? Lancet 1993; 341:355-357
147. Seckl JR. Glucocorticoids, feto-placental 11 beta- hydroxysteroid dehydrogenase type 2, and the early life origins of adult disease. Steroids 1997; 62:89-94.
148. Bohn MC. Granule cell genesis in the hippocampus of rats treated neonatally with hydrocortisone. Neuroscience 1980; 5:2003-2012
149. Gould E, Woolley CS, Cameron HA, Daniels DC, McEwen BS. Adrenal steroids regulate postnatal development of the rat dentate gyrus: II. Effects of glucocorticoids and mineralocorticoids on cell birth. J Comp Neurol 1991; 313:486-493
150. GouldE,WoolleyCS, McEwen BS.Adrenal steroids regulate postnatal development of the rat dentate gyrus: I. Effects of glucocorticoids on cell death. J Comp Neurol 1991; 313:479-485
151. Bottalico B, Larsson I, Brodszki J, Hernandez- Andrade E, Casslen B, Marsal K, Hansson SR. Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies. Placenta 2004; 25:518-529
152. Bzoskie L, Yen J, Tseng YT, Blount L, Kashiwai K, Padbury JF. Human placental norepinephrine transporter mRNA: expression and correlation with fetal condition at birth. Placenta 1997; 18:205-210
153. Jacob S,Moley KH. Gametes and embryo epigenetic reprogramming affect developmental outcome: implication for assisted reproductive technologies. Pediatr Res 2005; 58:437-446
154. Colvis CM, Pollock JD, Goodman RH, Impey S, Dunn J, Mandel G, Champagne PA,Mayford M, Korzus E, Kumar A, RenthalW, Theobald DE, Nestler EJ. Epigenetic mechanisms and gene networks in the nervous system. J Neurosci 2005; 25:10379-10389
155. Kumar A, Choi KH, Renthal W, Tsankova NM, Theobald DE, Truong HT, Russo SJ, Laplant Q, Sasaki TS, Whistler KN, Neve RL, Self DW, Nestler EJ. Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron 2005; 48:303-314
156. Loeber R, Burke JD, Lahey BB,Winters A, ZeraM. Oppositional defiant and conduct disorder: a review of the past 10 years, part I. J Am Acad Child Adolesc Psychiatry 2000; 39:1468-1484
157. Ellickson PL, Tucker JS, KleinDJ. High-risk behaviors associated with early smoking: results from a 5-year follow-up. J Adolesc Health 2001; 28:465-473
158. Hawkins JD, Graham JW, Maguin E, Abbott R, Hill KG, Catalano RF. Exploring the effects of age of alcohol use initiation and psychosocial risk factors on subsequent alcohol misuse. J Stud Alcohol 1997; 58: 280-290
159. Brook JS, Whiteman MM, Finch S. Childhood aggression, adolescent delinquency, and drug use: a longitudinal study. J Genet Psychol 1992; 153:369-383
160. Tarter R,Vanyukov M, Giancola P, Dawes M, Blackson T, Mezzich A, Clark DB. Etiology of early age onset substance use disorder: a maturational perspective. Dev Psychopathol 1999; 11:657-683
161. Blackson TC, Butler T, Belsky J, Ammerman RT, Shaw DS, Tarter RE. Individual traits and family contexts predict sons' externalizing behavior and preliminary relative risk ratios for conduct disorder and substance use disorder outcomes. Drug Alcohol Depend 1999; 56:115-131
162. Chassin L, Barrera MJ. Substance use escalation and substance use restraint among adolescent children of alcoholics. Psychol Addict Bahav 1993; 7:3-20.
163. Tarter RE, Blackson T, Brigham J, Moss H, Caprara GV. The association between childhood irritability and liability to substance use in early adolescence: a 2-year follow-up study of boys at risk for substance abuse. Drug Alcohol Depend 1995; 39:253-261
164. Clark DB, Parker AM, Lynch KG. Psychopathology and substance-related problems during early adolescence: a survival analysis. J Clin Child Psychol 1999; 28: 333-341
165. Aytaclar S, Tarter RE, Kirisci L, Lu S. Association between hyperactivity and executive cognitive functioning in childhood and substance use in early adolescence. J Am Acad Child Adolesc Psychiatry 1999; 38:172-178
166. Giancola PR, Martin CS, Tarter RE, Pelham WE, Moss HB. Executive cognitive functioning and aggressive behavior in preadolescent boys at high risk for substance abuse. J Stud Alcohol 1996; 57:352-359
167. Shoal G, Giancola P. Executive cognitive functioning, negative affectivity, and drug use in adolescent boys with and without a family history of a substance use disorder. J Child Adolesc Subst Abuse 2001; 10:111-121 (Pubitemid 33683341)
168. Tarter RE, Kirisci L, Mezzich A, Cornelius JR, Pajer K, Vanyukov M, Gardner W, Blackson T, Clark D. Neurobehavioral disinhibition in childhood predicts early age at onset of substance use disorder. Am J Psychiatry 2003; 160:1078-1085
169. Volkow ND, Li TK. Drugs and alcohol: treating and preventing abuse, addiction and their medical consequences. Pharmacol Ther 2005; 108:3-17.
170. Sowell ER, Thompson PM, Peterson BS, Mattson SN, Welcome SE, Henkenius AL, Riley EP, Jernigan TL, Toga AW. Mapping cortical gray matter asymmetry patterns in adolescents with heavy prenatal alcohol exposure. Neuroimage 2002; 17:1807-1819
171. Sowell ER, Thompson PM, Toga AW. Mapping changes in the human cortex throughout the span of life. Neuroscientist 2004; 10:372-392
172. Barnea-Goraly N, Eliez S, Menon V, Bammer R, Reiss AL. Arithmetic ability and parietal alterations: a diffusion tensor imaging study in velocardiofacial syndrome. Brain Res Cogn Brain Res 2005; 25:735-740
173. Giedd J. Brain development, IX: human brain growth. Am J Psychiatry 1999; 156:4.
174. Paus T, Zijdenbos A, Worsley K, Collins DL, Blumenthal J, Giedd JN, et al. Structural maturation of neural pathways in children and adolescents: in vivo study. Science 1999; 283:1908-1911
175. Bauer LO, Hesselbrock VM. P300 decrements in teenagers with conduct problems: implications for substance abuse risk and brain development. Biol Psychiatry 1999; 46:263-272
176. Giancola P, Tarter R. Executive cognitive functioning and risk for substance abuse. Psychol Sci 1999; 10:203-205
177. Schweinsburg AD, Paulus MP, Barlett VC, Killeen LA, Caldwell LC, Pulido C, Brown SA, Tapert SF. An FMRI study of response inhibition in youths with a family history of alcoholism. Ann N Y Acad Sci 2004; 1021:391-394
178. Chambers RA, Taylor JR, Potenza MN. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability.AmJ Psychiatry 2003; 160:1041-1052
179. Fuster JM. Executive frontal functions. Exp Brain Res 2000; 133:66-70.
180. Spear L. Neurobehavioral changes in adolescence. Curr Dir Psycholog Sci 2000; 9:111-114
181. Romeo RD, McEwen BS. Stress and the adolescent brain. Ann N Y Acad Sci 2006; 1094:202-214
182. Diorio D, Viau V, Meaney MJ. The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. J Neurosci 1993; 13:3839-3847
183. McEwen BS, De Kloet ER, Rostene W. Adrenal steroid receptors and actions in the nervous system. Physiol Rev 1986; 66:1121-1188
184. Meaney MJ, Aitken DH. Dexamethasone binding in rat frontal cortex. Brain Res 1985; 328:176-180
185. Patel PD, Lopez JF, Lyons DM, Burke S, Wallace M, Schatzberg AF. Glucocorticoid and mineralocorticoid receptormRNAexpression in squirrel monkey brain. J Psychiatr Res 2000; 34:383-392
186. Sanchez MM, Young LJ, Plotsky PM, Insel TR. Distribution of corticosteroid receptors in the rhesus brain: relative absence of glucocorticoid receptors in the hippocampal formation. J Neurosci 2000; 20:4657-4668
187. Chelonis JJ, Gillam MP, Paule MG. The effects of prenatal cocaine exposure on reversal learning using a simple visual discrimination task in rhesus monkeys. Neurotoxicol Teratol 2003; 25:437-446
188. Paule MG, Gillam MP, Allen RR, Chelonis JJ. Effects of chronic in utero exposure to cocaine on behavioral adaptability in rhesus monkey offspring when examined in adulthood. Ann N Y Acad Sci 2000; 914:412-417
189. Isgor C, Kabbaj M, Akil H, Watson SJ. Delayed effects of chronic variable stress during peripubertal-juvenile period on hippocampal morphology and on cognitive and stress axis functions in rats. Hippocampus 2004; 14:636-648
190. McEwen BS. Glucocorticoids, depression, and mood disorders: structural remodeling in the brain. Metabolism 2005; 54(5 Suppl 1):20-23
191. Radley JJ, Rocher AB, Miller M, Janssen WG, Liston C, Hof PR,McEwen BS,Morrison JH. Repeated stress induces dendritic spine loss in the rat medial prefrontal cortex. Cereb Cortex 2006; 16:313-320